FDMT
4D Molecular Therapeutics Inc
12.90$
-5.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 90.8% | 87.3% | 85.0% | 89.1% | 84.6% | 77.6% | 64.5% | 64.0% | 73.7% | 72.9% | 79.0% | 77.7% | |
| 76.2% | 73.3% | 43.8% | 30.5% | 31.0% | 26.6% | 25.9% | 16.3% | 11.5% | 10.6% | 14.1% | 14.3% | |
| 88.4% | 84.8% | 83.5% | 87.4% | 83.1% | 75.8% | 62.3% | 61.9% | 72.0% | 71.1% | 76.2% | 73.4% | |
| – | – | – | – | – | – | – | – | – | – | – | 0.9% | |
| 8.8% | 9.4% | 4.7% | 5.1% | 8.5% | 8.9% | 8.9% | 11.1% | 13.0% | 10.8% | 11.9% | 17.2% | |
| 5.0% | 5.6% | 2.6% | 3.1% | 4.9% | 5.2% | 5.2% | 7.3% | 8.8% | 7.8% | 8.5% | 9.7% | |
| 0.9% | 0.9% | 0.5% | 0.5% | 0.8% | 1.0% | 1.1% | 1.2% | 1.3% | 1.0% | 1.1% | 1.1% | |
| 1.3% | 1.0% | 0.7% | 0.6% | 0.5% | 0.8% | 0.8% | 1.8% | 1.6% | 2.0% | 2.9% | 2.5% | |
| – | – | – | – | – | – | – | – | – | – | – | 4.0% | |
| 91.2% | 90.6% | 95.3% | 94.9% | 91.5% | 91.1% | 91.1% | 88.9% | 87.0% | 89.2% | 88.1% | 82.8% | |
| -105.9% | -122.2% | -71.1% | -77.8% | -87.2% | -102.8% | -121.0% | -143.3% | -173.5% | -126.4% | -153.1% | -174.2% | |
| 11.7% | 11.5% | 7.8% | 8.9% | 9.2% | 9.6% | 10.8% | 11.8% | 13.2% | 10.2% | 13.3% | 14.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.